Rapid HIV Testing in NJ - PowerPoint PPT Presentation

1 / 10
About This Presentation
Title:

Rapid HIV Testing in NJ

Description:

... Wood Johnson Medical School. Lab Director, NJHIV rapid testing program. New Jersey Rapid HIV testing. Subset of State funded CTS sites. 23 agencies (grantees) ... – PowerPoint PPT presentation

Number of Views:46
Avg rating:3.0/5.0
Slides: 11
Provided by: cad92
Learn more at: http://www.fda.gov
Category:

less

Transcript and Presenter's Notes

Title: Rapid HIV Testing in NJ


1
Rapid HIV Testing in NJ
  • Evan M. Cadoff, M.D.
  • Professor of Pathology and Laboratory Medicine
  • UMDNJ Robert Wood Johnson Medical School
  • Lab Director, NJHIV rapid testing program

2
New Jersey Rapid HIV testing Subset of State
funded CTS sites 23 agencies (grantees) 117
licensed testing sites 138 trained
counselors 25,000 tests a year (60
oral) OraQuick since November 2003
11/11/2009
3
New Jersey rapid HIV testing
  • 23 agencies (grantees)
  • 117 licensed testing sites
  • 138 trained counselors
  • 25,000 tests a year (60 oral)
  • OraQuick since November 2003

4
HIV Testing in New Jersey
Rapid HIV Testing Introduced
5
Specificity
  • Blood gt99.9
  • Oral gt99.6
  • No increase last Fall (as SF and NY)
  • Not an issue, with 138 counselors at 117 sites

6
Counseling
  • FDA proposal does not include a target
  • Our sites 99.9 get pre and post test counseling
  • But funding depends on documenting counseling
  • Pre rapid testing, and preliminary positive rapid
    testing
  • 66 get post test counseling
  • Non-scientific review of Obstetric practices
  • Virtually no counseling

7
Counseling false positives
  • Rare event for trained counselors
  • Trained counselors uncomfortable and often
    incorrect
  • Clinicians may need assistance
  • Clinicians may need assistance to follow
    preliminary positives

8
Counseling
  • Target should be substantial equivalence to
    actual current practices, not an artificial
    higher standard

9
Phase I professional vs OTC?
  • False positives due to over sampling
  • Dont mention to consumers, or theyll do it
  • So dont repeat Phase I studies
  • False positives due to high storage temperature
  • Repeat flex studies with higher stress?

10
Summary
  • OTC increases knowledge of HIV status
  • Specificity is not an issue
  • Evaluation of OTC counseling should be
    equivalence to typical, not ideal current
    practice
  • Re-evaluate flex studies for temperature
    sensitivity
Write a Comment
User Comments (0)
About PowerShow.com